SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-22-035364
Filing Date
2022-03-18
Accepted
2022-03-18 09:03:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 425 tm229691d1_8k.htm 425 61787
2 EXHIBIT 2.1 tm229691d1_ex2-1.htm EX-2.1 601367
3 EXHIBIT 10.1 tm229691d1_ex10-1.htm EX-10.1 76715
4 EXHIBIT 10.2 tm229691d1_ex10-2.htm EX-10.2 47223
5 EXHIBIT 10.3 tm229691d1_ex10-3.htm EX-10.3 150504
6 EXHIBIT 99.1 tm229691d1_ex99-1.htm EX-99.1 44570
7 EXHIBIT 99.2 tm229691d1_ex99-2.htm EX-99.2 48259
8 GRAPHIC tm229691d1_ex99-1img01.jpg GRAPHIC 6006
9 GRAPHIC tm229691d1_ex99-2img01.jpg GRAPHIC 5964
  Complete submission text file 0001104659-22-035364.txt   1048973
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filed by) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36150 | Film No.: 22751214
SIC: 2836 Biological Products, (No Diagnostic Substances)